首页> 外国专利> Antibodies that recognize carbohydrate-containing epitopes of CD-43 and CEA expressed in cancer cells and methods of using the same

Antibodies that recognize carbohydrate-containing epitopes of CD-43 and CEA expressed in cancer cells and methods of using the same

机译:识别癌细胞中表达的CD-43和CEA含碳水化合物表位的抗体及其使用方法

摘要

The present invention provides novel antibodies specifically bind to an epitope on CD43 and CEA expressed on nonhematopoietic cancer cells, but do not specifically bind to a CD43 expressed by a leukocyte or by a Jurkat cell, and is capable of inducing apoptosis of the nonhematopoietic cancer cell after binding to the epitope on cell surface of the nonhematopoietic cancer cell in the absence of cytotoxin conjugation and immune effector function, wherein the epitope comprises a carbohydrate structure and the binding of the antibody to the epitope is inhibited by a carbohydrate comprising a Lea structure, a Lea-lactose structure, a LNDFH II structure, or a LNT structure. In addition, the present invention also provides use of the antibodies described herein for diagnostic and therapeutic purposes.
机译:本发明提供了新型抗体,其特异性结合非造血细胞癌细胞上表达的CD43和CEA的表位,但不特异性结合白细胞或Jurkat细胞表达的CD43,并且能够诱导非造血细胞癌细胞的凋亡。在不存在细胞毒素结合和免疫效应功能的情况下与非造血性癌细胞的细胞表面上的表位结合后,其中该表位包含碳水化合物结构,并且抗体与该表位的结合被包含Lea结构的碳水化合物抑制, Lea-乳糖结构,LNDFH II结构或LNT结构。另外,本发明还提供了本文所述抗体用于诊断和治疗目的的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号